CB
BMY.RT

CNB Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

CNB Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,611
Closed -$1K – 450
2020
Q4 		$1K Hold
1,611
– – ﹤0.01% 428
2020
Q3 		$3K Sell
1,611
-790
-33% -$2.26K ﹤0.01% 356
2020
Q2 		$9K Sell
2,401
-48
-2% -$173 0.01% 337
2020
Q1 		$10K Sell
2,449
-136
-5% -$448 0.01% 305
2019
Q4 		$7K Buy
+2,585
New +$6.72K 0.01% 347

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

CNB Bank's BMY.RT Position: Q1 2021 in Review

CNB Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,611 shares — an estimated $1K sold.

CNB Bank first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $10K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • CNB Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • CNB Bank sold 1,611 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1K.
  • CNB Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • CNB Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $10K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on CNB Bank's 13F filing for Q1 2021, filed 3 May 2021.